Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

References for PMC Articles for PubMed (Select 19208833)

1.

Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.

Smallridge RC, Marlow LA, Copland JA.

Endocr Relat Cancer. 2009 Mar;16(1):17-44. doi: 10.1677/ERC-08-0154. Epub 2008 Nov 5. Review.

2.

Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.

Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland JA, Smallridge RC, Haugen BR.

J Clin Endocrinol Metab. 2008 Nov;93(11):4331-41. doi: 10.1210/jc.2008-1102. Epub 2008 Aug 19.

3.

Fat and beyond: the diverse biology of PPARgamma.

Tontonoz P, Spiegelman BM.

Annu Rev Biochem. 2008;77:289-312. doi: 10.1146/annurev.biochem.77.061307.091829. Review.

PMID:
18518822
4.

In vivo restoration of RhoB expression leads to ovarian tumor regression.

Couderc B, Pradines A, Rafii A, Golzio M, Deviers A, Allal C, Berg D, Penary M, Teissie J, Favre G.

Cancer Gene Ther. 2008 Jul;15(7):456-64. doi: 10.1038/cgt.2008.12. Epub 2008 Mar 14.

PMID:
18340357
5.

Epigenetic regulation of RhoB loss of expression in lung cancer.

Mazières J, Tovar D, He B, Nieto-Acosta J, Marty-Detraves C, Clanet C, Pradines A, Jablons D, Favre G.

BMC Cancer. 2007 Nov 30;7:220.

6.

Functional genomic analysis reveals cross-talk between peroxisome proliferator-activated receptor gamma and calcium signaling in human colorectal cancer cells.

Bush CR, Havens JM, Necela BM, Su W, Chen L, Yanagisawa M, Anastasiadis PZ, Guerra R, Luxon BA, Thompson EA.

J Biol Chem. 2007 Aug 10;282(32):23387-401. Epub 2007 Jun 12.

7.
8.

Cancer statistics, 2007.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ.

CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66.

PMID:
17237035
9.

Molecular diagnosis of a BRAF papillary thyroid carcinoma with multiple chromosome abnormalities and rare adrenal and hypothalamic metastases.

Copland JA, Marlow LA, Williams SF, Grebe SK, Gumz ML, Maples WJ, Silverman VE, Smallridge RC.

Thyroid. 2006 Dec;16(12):1293-302.

PMID:
17199440
10.

Effects of PPARgamma agonists on cell survival and focal adhesions in a Chinese thyroid carcinoma cell line.

Chen Y, Wang SM, Wu JC, Huang SH.

J Cell Biochem. 2006 Jul 1;98(4):1021-35.

PMID:
16795079
11.

Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells.

Aiello A, Pandini G, Frasca F, Conte E, Murabito A, Sacco A, Genua M, Vigneri R, Belfiore A.

Endocrinology. 2006 Sep;147(9):4463-75. Epub 2006 Jun 15.

PMID:
16777971
12.

RS5444, a novel PPARgamma agonist, regulates aspects of the differentiated phenotype in nontransformed intestinal epithelial cells.

Chen L, Bush CR, Necela BM, Su W, Yanagisawa M, Anastasiadis PZ, Fields AP, Thompson EA.

Mol Cell Endocrinol. 2006 Jun 7;251(1-2):17-32. Epub 2006 Mar 29.

PMID:
16574311
13.

Additive antitumor effects of gefitinib and imatinib on anaplastic thyroid cancer cells.

Kurebayashi J, Okubo S, Yamamoto Y, Ikeda M, Tanaka K, Otsuki T, Sonoo H.

Cancer Chemother Pharmacol. 2006 Oct;58(4):460-70. Epub 2006 Jan 25.

PMID:
16435154
14.

Novel high-affinity PPARgamma agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1.

Copland JA, Marlow LA, Kurakata S, Fujiwara K, Wong AK, Kreinest PA, Williams SF, Haugen BR, Klopper JP, Smallridge RC.

Oncogene. 2006 Apr 13;25(16):2304-17.

PMID:
16331265
15.

RhoB in cancer suppression.

Huang M, Prendergast GC.

Histol Histopathol. 2006 Feb;21(2):213-8. Review.

PMID:
16329046
16.

PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway.

Kato Y, Ying H, Zhao L, Furuya F, Araki O, Willingham MC, Cheng SY.

Oncogene. 2006 May 4;25(19):2736-47.

PMID:
16314832
17.

Novel histone deacetylase inhibitors in the treatment of thyroid cancer.

Mitsiades CS, Poulaki V, McMullan C, Negri J, Fanourakis G, Goudopoulou A, Richon VM, Marks PA, Mitsiades N.

Clin Cancer Res. 2005 May 15;11(10):3958-65.

18.

Palmitoylated cysteine 192 is required for RhoB tumor-suppressive and apoptotic activities.

Wang DA, Sebti SM.

J Biol Chem. 2005 May 13;280(19):19243-9. Epub 2005 Feb 15.

19.

Cyclin B1 is a critical target of RhoB in the cell suicide program triggered by farnesyl transferase inhibition.

Kamasani U, Huang M, Duhadaway JB, Prochownik EV, Donover PS, Prendergast GC.

Cancer Res. 2004 Nov 15;64(22):8389-96.

20.

RhoB mRNA is stabilized by HuR after UV light.

Westmark CJ, Bartleson VB, Malter JS.

Oncogene. 2005 Jan 13;24(3):502-11.

PMID:
15543229
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk